輸入代號或公司名稱後按 Enter
4726

永昕

-0.45 (-1.93%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
22.90242成交張數本益比3.37股價淨值比0.00%殖利率2026-09-11資料日期

毛利率、營業利益率、淨利率

單季;近十年

單季營收

億元

季度營收(億)營收年增毛利(億)毛利率營業利益(億)營業利益率淨利率
2026Q22.00.3%-0.2-9.0%-0.7-34.3%-40.7%
2026Q12.061.7%-0.6-30.0%-1.1-55.5%-59.4%
2025Q42.846.7%0.11.8%-0.5-18.3%-18.4%
2025Q31.3-37.2%-0.7-49.7%-1.3-95.5%-98.9%
2025Q22.01.0%-0.4-21.1%-1.0-48.5%-67.7%
2025Q11.251.8%-0.8-64.5%-1.3-105.3%-106.1%
2024Q41.96.0%-0.4-18.2%-0.9-47.1%-42.9%
2024Q32.184.6%-0.7-32.9%-1.3-60.5%-70.1%
2024Q22.0-8.0%-0.5-25.2%-1.1-53.7%-50.6%
2024Q10.8-42.0%-0.9-108.1%-1.4-169.4%-169.1%
2023Q41.8-6.6%-0.8-42.2%-1.2-67.2%-83.4%
2023Q31.1-28.9%-1.0-89.8%-1.4-121.6%-107.7%
2023Q22.243.8%-0.9-42.3%-1.8-81.2%-76.8%
2023Q11.4-38.6%-1.0-75.3%-1.6-118.8%-174.1%
2022Q42.0-11.3%-0.6-33.2%-1.7-89.2%-93.2%
2022Q31.63.1%-0.7-46.5%-1.6-102.5%-108.6%
2022Q21.542.0%-0.5-35.0%-1.2-81.1%-76.8%
2022Q12.3-22.8%0.834.8%0.27.1%8.1%
2021Q42.224.0%0.29.0%-0.5-24.0%-25.3%
2021Q31.54.1%-0.2-14.4%-0.8-53.3%-51.3%
2021Q21.1-60.3%-0.3-24.4%-0.6-60.6%-64.7%
2021Q12.9318.3%1.756.8%1.139.2%39.1%
2020Q41.835.5%0.317.5%-0.1-3.9%-7.0%
2020Q31.590.0%0.212.4%-0.1-9.4%-9.2%
2020Q22.7134.0%1.347.9%0.830.6%29.2%
2020Q10.75.2%0.111.4%-0.3-37.1%-30.9%
2019Q41.352.2%0.537.3%-0.4-30.2%-32.5%
2019Q30.831.9%0.113.7%-1.0-123.5%-119.2%
2019Q21.1137.3%0.543.1%-0.3-30.4%-26.4%
2019Q10.7280.5%0.235.1%-0.6-89.3%-78.6%
2018Q40.9-7.2%0.227.5%-1.1-128.7%-107.5%
2018Q30.6-53.2%0.115.3%-0.6-105.6%-94.3%
2018Q20.5-34.6%0.09.6%-0.8-162.5%-114.7%
2018Q10.2-30.9%-0.2-133.5%-0.7-402.5%-402.7%
2017Q40.926.8%0.551.0%-0.4-44.2%-123.4%
2017Q31.344.9%0.861.7%0.214.9%17.5%
2017Q20.7146.3%0.340.3%-0.3-41.5%-30.9%
2017Q10.3153.1%-0.2-61.0%-0.7-271.4%-288.3%
2016Q40.70.338.6%-0.5-66.8%-30.8%
2016Q30.90.448.0%-0.3-35.7%-26.8%